
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia
Author(s) -
Sumithira Vasu,
Jessica K. Altman,
Brian Uy,
Martin S. Tallman,
Ivana Gojo,
Gerard Lozanski,
Ute Burkard,
Annika Osswald,
Pamela James,
Björn Rüter,
William Blum
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2020.274118
Subject(s) - monoclonal antibody , myeloid leukemia , medicine , virology , leukemia , monoclonal , antibody , myeloid , cancer research , immunology
Not available.